Evidence map›Paper›PMID 29610195›Full record

ArticleAntimicrobial agents and chemotherapy2018

Overexpression of the Efflux Pumps SmeVWX and SmeDEF Is a Major Cause of Resistance to Co-trimoxazole in Stenotrophomonas maltophilia.

María Blanca Sánchez, José Luis Martínez

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Observational
  2. Treatment outcomes of combination versus monotherapy inAntimicrobial agents and chemotherapy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Mutation ofAntibiotics (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Frontiers in microbiology · 2024
    Review
  15. Versatility ofHeliyon · 2023
    Review
  16. Review
  17. Article
  18. In-Depth Analysis of an Obligate AnaerobeAnimals : an open access journal from MDPI · 2022
    Article
  19. Clinical challenges treatingJAC-antimicrobial resistance · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

María Blanca SánchezDepartamento de Biotecnología Microbiana, Centro Nacional de Biotecnología, CSIC, Cantoblanco, Madrid, Spain.
José Luis MartínezDepartamento de Biotecnología Microbiana, Centro Nacional de Biotecnología, CSIC, Cantoblanco, Madrid, Spain jlmtnez@cnb.csic.es.
Centro Nacional de Biotecnología · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Co-trimoxazole is one of the antimicrobials of choice for treating

Indexed as

Anti-Bacterial AgentsBacterial ProteinsMembrane Transport ProteinsMicrobial Sensitivity TestsMutationStenotrophomonas maltophiliaTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsBacterial ProteinsMembrane Transport ProteinsTrimethoprim, Sulfamethoxazole Drug Combinationco-trimoxazoleSmeDEFSmeVWXStenotrophomonas maltophilia

Identifiers

PMID29610195
PMCPMC5971588
OpenAlexW2794594742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.